跳至主要内容
临床试验/TCTR20210423001
TCTR20210423001已完成2 期

Effectiveness of zinc supplement in minimal hepatic encephalophathy: A prospective, randomized controlled trial

avamindradhiraj University Research Fund0 个研究点目标入组 69 人开始时间: 2021年4月23日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
69

研究概览

简要总结

Significant improvement of NP tests was established in zinc supplement group when compared with placebo (NCT-A p 0.029, NCT-B, p 0.008, SDT, p 0.002 , DST, p below 0.001). Significant improvement of HRQOL assessed by SF-36 score was seen only in the zinc group, p below 0.001. In the zinc supplement group, not only the improvement of psychomotor performance but quality of life were achieved irrespective of baseline zinc level.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1. Minimal hepatic encephalopathy
  • 2. cirrhosis

排除标准

  • 1.history of overt HE
  • 2.gastrointestinal bleeding and spontaneous bacterial peritonitis in past 6 weeks
  • 3.neurological diseases causes of impaired cognitive function eg. Parkinson disease, Alzheimer disease
  • 4.recent alcohol consumption within 6 weeks
  • 5.on medication affecting psychometric performances like benzodiazepines, antiepileptics or psychotropic drugs
  • 6.concurrent with hepatocellular carcinoma or active other malignancy
  • 7.pregnancy
  • 8.blindness
  • 9.cannot read and write

研究者

发起方
avamindradhiraj University Research Fund

相似试验